Qiagen N.V.
QGEN
주식 순위
#2039
Qiagen N.V. provides sample to insight solutions that transform biological... Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
주가
$49.39
시가총액
$10.18B
변동 (1일)
6.12%
변동 (1년)
1.47%
국가
NL
거래 Qiagen N.V. (QGEN)
카테고리
Healthcare
Qiagen N.V. (QGEN)의 수익
Jun 2026 기준 수익 TTM: $461.83M
Qiagen N.V.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $461.83M입니다. 2024년에 회사는 $121.15M의 수익을 올렸으며 이는 2023년의 수익 $429.81M과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Qiagen N.V.의 수익 기록 (2000 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $461.83M | -5.80% |
| 2025 | $490.27M | 304.69% |
| 2024 | $121.15M | -71.81% |
| 2023 | $429.81M | -16.15% |
| 2022 | $512.60M | -18.09% |
| 2021 | $625.83M | 42.41% |
| 2020 | $439.47M | -665.05% |
| 2019 | $-77.78M | -134.45% |
| 2018 | $225.74M | 97.37% |
| 2017 | $114.38M | 100.98% |
| 2016 | $56.91M | -58.25% |
| 2015 | $136.30M | 14.17% |
| 2014 | $119.39M | 219.75% |
| 2013 | $37.34M | -74.28% |
| 2012 | $145.15M | 50.87% |
| 2011 | $96.21M | -44.42% |
| 2010 | $173.12M | 0.46% |
| 2009 | $172.33M | 44.47% |
| 2008 | $119.29M | 57.52% |
| 2007 | $75.73M | -28.61% |
| 2006 | $106.07M | 9.05% |
| 2005 | $97.26M | 33.81% |
| 2004 | $72.69M | 8.08% |
| 2003 | $67.26M | 73.05% |
| 2002 | $38.87M | -30.99% |
| 2001 | $56.32M | 43.94% |
| 2000 | $39.12M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $7.61B | 1,547.58% |
US
|
|
| $4.76B | 931.12% |
US
|
|
| $-252.70M | -154.72% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 259.01% |
US
|
